Large Language Models Meet Biomedical Knowledge Graphs for Mechanistically Grounded Therapeutic Prioritization
arXiv AIArchived Apr 23, 2026✓ Full text saved
arXiv:2604.19815v1 Announce Type: new Abstract: Drug repurposing is often framed as a candidate identification task, but existing approaches provide limited guidance for distinguishing biologically plausible candidates from historically well-connected ones. Here we introduce DrugKLM, a hybrid framework that integrates biomedical knowledge graph structure with large language model-based mechanistic reasoning to enable mechanistically grounded therapeutic prioritization. Across benchmark datasets,
Full text archived locally
✦ AI Summary· Claude Sonnet
Computer Science > Artificial Intelligence
[Submitted on 17 Apr 2026]
Large Language Models Meet Biomedical Knowledge Graphs for Mechanistically Grounded Therapeutic Prioritization
Chih-Hsuan Wei, Chi-Ping Day, Zhizheng Wang, Christine C. Alewine, Betty Tyler, Hasan Slika, David Saraf, Chin-Hsien Tai, Joey Chan, Robert Leaman, Zhiyong Lu
Drug repurposing is often framed as a candidate identification task, but existing approaches provide limited guidance for distinguishing biologically plausible candidates from historically well-connected ones. Here we introduce DrugKLM, a hybrid framework that integrates biomedical knowledge graph structure with large language model-based mechanistic reasoning to enable mechanistically grounded therapeutic prioritization. Across benchmark datasets, DrugKLM outperforms knowledge graph-only and language model-only baselines, including TxGNN. Beyond improved recall, DrugKLM confidence scores exhibit functional alignment with molecular phenotypes: higher scores are associated with transcriptional signatures linked to improved survival across 12 TCGA cancers. The scoring framework preferentially captures biologically perturbational signals rather than historical indication patterns. Expert curation across five cancers further reveals systematic differences in prioritization behavior, with DrugKLM elevating candidates supported by coherent mechanistic rationale and disease-specific clinical context. Together, these results establish DrugKLM as an evidence-integrative framework that translates heterogeneous biomedical data into mechanistically interpretable and clinically grounded therapeutic hypotheses.
Comments: 24 pages, 5 figures in main text
Subjects: Artificial Intelligence (cs.AI)
Cite as: arXiv:2604.19815 [cs.AI]
(or arXiv:2604.19815v1 [cs.AI] for this version)
https://doi.org/10.48550/arXiv.2604.19815
Focus to learn more
Submission history
From: Chih-Hsuan Wei [view email]
[v1] Fri, 17 Apr 2026 15:29:52 UTC (1,315 KB)
Access Paper:
view license
Current browse context:
cs.AI
< prev | next >
new | recent | 2026-04
Change to browse by:
cs
References & Citations
NASA ADS
Google Scholar
Semantic Scholar
Export BibTeX Citation
Bookmark
Bibliographic Tools
Bibliographic and Citation Tools
Bibliographic Explorer Toggle
Bibliographic Explorer (What is the Explorer?)
Connected Papers Toggle
Connected Papers (What is Connected Papers?)
Litmaps Toggle
Litmaps (What is Litmaps?)
scite.ai Toggle
scite Smart Citations (What are Smart Citations?)
Code, Data, Media
Demos
Related Papers
About arXivLabs
Which authors of this paper are endorsers? | Disable MathJax (What is MathJax?)